Alex Sparreboom

发表

Modeling Mechanisms of In Vivo Variability in Methotrexate Accumulation and Folate Pathway Inhibition in Acute Lymphoblastic Leukemia Cells

Ching-Hon Pui, Mary Relling, John C. Panetta, 2010, PLoS Comput. Biol..

Modulation of OATP1B-Type Transporter Function Alters Cellular Uptake and Disposition of Platinum Chemotherapeutics

Alex Sparreboom, A. Gibson, A. Sparreboom, 2013, Molecular Cancer Therapeutics.

Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 Polymorphisms with the Pharmacokinetics of Paclitaxel

Sharon Marsh, Mats O Karlsson, Howard L McLeod, 2005, Clinical Cancer Research.

Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes.

Alex Sparreboom, A. Sparreboom, S. Mielke, 2006, European journal of cancer.

Modulation of irinotecan metabolism by ketoconazole.

Ron H J Mathijssen, Alex Sparreboom, J. Verweij, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

Cheng Cheng, Ching-Hon Pui, Diana Chan, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype

Sharon Marsh, Howard L McLeod, Alex Sparreboom, 2004, Clinical pharmacology and therapeutics.

Pharmacogenetics of irinotecan metabolism and transport: an update.

Alex Sparreboom, A. Sparreboom, W. Figg, 2006, Toxicology in vitro : an international journal published in association with BIBRA.

Herbal remedies in the United States: potential adverse interactions with anticancer agents.

Alex Sparreboom, A. Sparreboom, W. Figg, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical pharmacokinetics of encapsulated oral 9‐aminocamptothecin in plasma and saliva

Alex Sparreboom, J. Verweij, A. Sparreboom, 1999, Clinical pharmacology and therapeutics.

Role of Formulation Vehicles in Taxane Pharmacology

Alex Sparreboom, J. Verweij, L. van Zuylen, 2001, Investigational New Drugs.

Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

Michael Hawkins, William D. Figg, Paul J. Williams, 2005, Clinical Cancer Research.

Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients

Jing Li, Manuel Hidalgo, Alex Sparreboom, 2007, Cancer biology & therapy.

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Ming Zhao, Alex Sparreboom, A. Wolff, 2004, Clinical Cancer Research.

Irinotecan pathway genotype analysis to predict pharmacokinetics.

Sharon Marsh, Ron H J Mathijssen, Mats O Karlsson, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

Neil Desai, Alex Sparreboom, A. Sparreboom, 2008, Clinical Cancer Research.